MDL 27266
MDL 27266 is an orally active NMDA receptor antagonist with neuroprotective effect. MDL 27266 is a broad-spectrum anticonvulsant agent[1].
Product Specifications
CAS Number
116114-14-8
UNSPSC
12352005
Target
IGluR
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
CCN1C(C2=CC=C(Cl)C=C2)=NN(C)C1=O
Molecular Formula
C11H12ClN3O
Molecular Weight
237.69
References & Citations
[1]Warner MA, et al. Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil. J Cereb Blood Flow Metab. 1991 Jul;11 (4) :600-10.|[2]White HS, et al. Anticonvulsant profile of MDL 27,266: an orally active, broad-spectrum anticonvulsant agent. Epilepsy Res. 1992 Sep;12 (3) :217-26.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NMDA Receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
306497-01 50 µg
SIVA1 (Apoptosis Regulatory Protein Siva, CD27-Binding Protein, CD27BP, SIVA1, SIVA) (HRP)
Sign In for Pricing
View Details 306497-02 100 µg
SIVA1 (Apoptosis Regulatory Protein Siva, CD27-Binding Protein, CD27BP, SIVA1, SIVA) (HRP)
Sign In for Pricing
View Details H1827-50H-APC 200 µL
HDAC1, CT (Histone Deacetylase 1, HD1, RPD3L1) (APC) discontinued
Sign In for Pricing
View Details 